SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin’s arm recalling 46,479 bottles of anti-viral medication Oseltamivir Phosphate in US market

15 Feb 2021 Evaluate

Lupin’s wholly-owned subsidiary -- Lupin Pharmaceuticals Inc, is recalling 46,479 bottles of anti-viral medication Oseltamivir Phosphate for Oral Suspension in the American market. The company has initiated the recall of the affected lot due to ‘Failed Impurities/Degradation Specifications’. The product has been manufactured at Lupin's Aurangabad (Maharashtra) based manufacturing plant. The company initiated the recall, which the US health regulator has classified as Class III, on January 21 this year. 

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2492.45 16.35 (0.66%)
06-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.05
Dr. Reddys Labs. 1368.75
Cipla 1471.25
Zydus Lifesciences 1148.05
Lupin 2492.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: